
Panriv-IV Injection
Marketer
Fedley Healthcare Private Limited
Salt Composition
Pantoprazole (40mg)
Overview Panriv-IV Injection
Stomach acid production is reduced by Intravenous Panriv, a medication treating acid-related gastrointestinal disorders including acid reflux, peptic ulcers, and Zollinger-Ellison syndrome. It alleviates symptoms and facilitates healing. Administered intravenously by medical professionals, Intravenous Panriv also prevents stress ulcers in critically ill patients and pre-anesthesia aspiration complications. Classified as a proton pump inhibitor (PPI), it's prescribed intravenously only when deemed more appropriate than oral administration by your physician. Dosage and treatment duration are determined by your individual needs and response, requiring adherence to the prescribed regimen despite rapid symptom resolution. Lifestyle modifications such as frequent, smaller meals and avoidance of caffeine, spicy, and fatty foods enhance treatment efficacy. Common, typically mild, side effects include nausea, vomiting, headache, dizziness, gas, diarrhea, abdominal pain, and thrombophlebitis (vein inflammation). Persistent or bothersome side effects necessitate medical consultation. Prolonged use, particularly exceeding one year or at higher doses, may increase bone fracture risk; discuss bone loss prevention strategies, such as calcium and vitamin D supplementation, with your doctor. Intravenous Panriv is contraindicated for individuals with severe liver disease, those on HIV medications, those with a history of similar medication allergies, or pre-existing osteoporosis. Pregnant or breastfeeding individuals should consult their physician before use. Alcohol consumption should be avoided due to its acid-stimulating effect. Refrain from operating machinery if dizziness or drowsiness occurs.
Primary Ingredients of Panriv-IV Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Panriv-IV Injection
Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Panriv-IV Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Panriv-IV Injection:
- Diarrhea
- Flatulence
- Headache
- Joint pain
- Nausea
- Stomach pain
- Vomiting
- Dizziness
- Thrombophlebitis
How to use Panriv-IV Injection:
This medication will be administered by your healthcare provider. Self-medication is not advised.
How Panriv-IV Injection works:
Panriv-IV, administered intravenously, is a proton pump inhibitor that decreases gastric acid production, thereby alleviating symptoms of acid indigestion and heartburn.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while receiving Panriv-IV Injection is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Administering Panriv-IV Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible hazards prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administering Panriv-IV Injection while breastfeeding appears to pose minimal risk. Available human data indicate negligible infant exposure to the medication.
DrivingCONSULT YOUR DOCTOR
The effect of Panriv-IV Injection on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Panriv-IV Injection presents no safety concerns for use in patients with renal impairment; dose modification is unnecessary.
LiverCAUTION
Administering Panriv-IV Injection requires careful consideration in individuals with advanced hepatic impairment. Dosage modification for Panriv-IV Injection might be necessary. Physician consultation is advised.
What if you forget to take Panriv-IV Injection :
Should you forget a scheduled dose of Panriv-IV Injection, seek medical advice from your physician.
Facts to Know About Panriv-IV Injection
| Label | Value |
|---|---|
| Chemical Type | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal System |
| Actions | Gastric acid suppressants |
